Lower riskMedical device recall · FDA · Published March 17, 2021
Change Healthcare Enterprise Viewer Software Defect May Cause Anchor Study Failure
Change Healthcare recalls Enterprise Viewer software versions 2.0 and 2:1 due to a software defect that may cause anchor study failures. Affected users should contact the company for updates.
“Change Healthcare Enterprise Viewer Software Defect May Cause Anchor Study Failure.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/63042-change-healthcare-enterprise-viewer-software-defect-may-cause-anchor-study. Based on FDA recall #Z-1508-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1508-2021%22&limit=1).
The FDA announced on March 17, 2021, that Change Healthcare Canada Company is recalling the Change Healthcare Enterprise Viewer due to a software defect that may prevent an anchor study from displaying. This voluntary Class II recall affects 28 units distributed domestically.
How to tell if you have it
Change Healthcare Enterprise Viewer
Change Healthcare Enterprise Viewer 2.0
Change Healthcare Enterprise Viewer 2.1
The hazard
According to the FDA, Change Healthcare has identified an intermittent software defect which may result in an anchor study failing to display.
Context
GovInfoNow's records show CHANGE HEALTHCARE CANADA COMPANY has 8 other recalls on record since 2020-02-10. Other recent recalls of similar products include GE Medical Systems Portrait Core Services SW Reload V1.1 Software Issue Recall (2026-07-20), GE Medical Systems Portrait Compute V1.2 Software Recall: Patient Monitoring Risk (2026-07-20), and GE Medical Systems Portrait Core Services Software V1.1 Recall: Patient Monitoring Risk (2026-07-20).
How to tell if you have this one
Check if you have the Change Healthcare Enterprise Viewer software versions 2.0 or 2.1. The product is used in healthcare settings for data analysis.
Brand
Change Healthcare
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Contact Manufacturer
Reach out to Change Healthcare for guidance on software updates or alternatives.
Where it went and when
Where it was distributed
Distributed in 18 states.
Listed by the agency
Not listed
FDA distribution: “Domestic Distribution only. IN, KY, CA, NY, WA, IL, IA, FL, TX, WA, MI, HI, AK, WI, WY, NE, AZ, OH, PA” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Alaska, Arizona, California, Florida, Hawaii, Illinois, Indiana, Iowa, Kentucky, Michigan, Nebraska, New York, Ohio, Pennsylvania, Texas, Washington, Wisconsin, Wyoming.
Recall timeline
FDA published this recall 49 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-1508-2021 (March 17, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1508-2021 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.